MD Anderson and SOPHiA GENETICS announce strategic collaboration to accelerate AI-driven precision oncology
The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics with MD Anderson’s clinical and scientific expertise to accelerate data-driven cancer care through new tools that can accurately analyze, interpret and translate diagnostic results into clinical practice.
As part of the collaboration, MD Anderson and SOPHiA GENETICS are...
